FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: referentieset voor associaties betreffende vervangende concepten (metadata)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
9093651000146111 referentieset voor associaties betreffende vervangende concepten nl Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)
9093661000146114 referentieset voor associaties betreffende vervangende concepten (metadata) nl Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Netherlands NRC maintained module (core metadata concept)


20431 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Product containing precisely bisoprolol fumarate 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely bosentan (as bosentan hydrochloride) 125 milligram/1 each conventional release oral tablet (clinical drug) Bosentan 125 mg oral tablet
Product containing precisely bosentan (as bosentan hydrochloride) 62.5 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely bosentan 62.5 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely bosutinib (as bosutinib monohydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Bosutinib 100 mg oral tablet
Product containing precisely bosutinib (as bosutinib monohydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Bosutinib 500 mg oral tablet
Product containing precisely bosutinib monohydrate 100 milligram/1 each conventional release oral tablet Bosutinib 100 mg oral tablet
Product containing precisely bosutinib monohydrate 500 milligram/1 each conventional release oral tablet Bosutinib 500 mg oral tablet
Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely bromfenac (as bromfenac sodium) 900 microgram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely bromocriptine 800 microgram/1 each conventional release oral tablet Product containing precisely bromocriptine (as bromocriptine mesilate) 800 microgram/1 each conventional release oral tablet (clinical drug)
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug)
Product containing precisely bupivacaine hydrochloride 312.5 milligram/250 milliliter conventional release solution for infusion bag Bupivacaine hydrochloride 1.25 mg/mL solution for injection
Product containing precisely buspirone 10 milligram/1 each conventional release oral tablet Buspirone hydrochloride 10 mg oral tablet
Product containing precisely buspirone 5 milligram/1 each conventional release oral tablet Buspirone hydrochloride 5 mg oral tablet
Product containing precisely canagliflozin (as canagliflozin hemihydrate) 100 milligram/1 each conventional release oral tablet (clinical drug) Canagliflozin 100 mg oral tablet
Product containing precisely canakinumab 150 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Canakinumab 150 mg powder for solution for injection vial
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug)
Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oral gel (clinical drug) Carbenoxolone 20 mg/g oromucosal gel
Product containing precisely carbidopa (as carbidopa monohydrate) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa (as carbidopa monohydrate) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Product containing precisely carbidopa (as carbidopa monohydrate) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa (as carbidopa monohydrate) 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet Carbidopa anhydrous (as carbidopa) 12.5 mg and levodopa 50 mg oral tablet
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg oral tablet
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbidopa 25 milligram/1 each conventional release oral tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely carbinoxamine 4 milligram/1 each conventional release oral tablet Carbinoxamine maleate 4 mg oral tablet
Product containing precisely carmellose 166 milligram/1 gram conventional release oral paste (clinical drug) Carmellose 166 mg/g oromucosal paste
Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely carmellose sodium 10 milligram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye solution (clinical drug) Product containing precisely carmellose sodium 5 milligram/1 milliliter conventional release eye drops (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 25 milligram/1 milliliter conventional release oral suspension Product containing precisely cefaclor anhydrous (as cefaclor) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Product containing precisely cefaclor 250 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet Product containing precisely cefaclor 375 milligram/1 each prolonged-release oral tablet (clinical drug)
Product containing precisely cefaclor (as cefaclor monohydrate) 50 milligram/1 milliliter conventional release oral suspension Cefaclor 50 mg/mL oral suspension
Product containing precisely cefaclor (as cefaclor monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Cefaclor 500 mg oral capsule
Product containing precisely cefaclor anhydrous (as cefaclor) 250 milligram/1 each conventional release chewable tablet (clinical drug) Product containing precisely cefaclor 250 milligram/1 each conventional release chewable tablet (clinical drug)
Product containing precisely cefadroxil (as cefadroxil monohydrate) 100 milligram/1 milliliter conventional release oral suspension Cefadroxil 100 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 25 milligram/1 milliliter conventional release oral suspension Cefadroxil 25 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 50 milligram/1 milliliter conventional release oral suspension Cefadroxil 50 mg/mL oral suspension
Product containing precisely cefadroxil (as cefadroxil monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Product containing precisely cefadroxil 500 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Cefalexin 500 mg oral capsule
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) Cefalexin 25 mg/mL oral solution
Product containing precisely cefalexin hydrochloride 500 milligram/1 each conventional release oral tablet Cefalexin 500 mg oral tablet
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral capsule Product containing precisely cefalexin 250 milligram/1 each conventional release oral capsule (clinical drug)
Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet Product containing precisely cefalexin 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefalexin monohydrate 333 milligram/1 each conventional release oral capsule Cefalexin 333 mg oral capsule
Product containing precisely cefalexin monohydrate 500 milligram/1 each conventional release oral capsule Cefalexin 500 mg oral capsule
Product containing precisely cefalexin monohydrate 750 milligram/1 each conventional release oral capsule Cefalexin 750 mg oral capsule
Product containing precisely cefixime anhydrous (as cefixime) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Cefixime 40 mg/mL oral suspension
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Cefotaxime (as cefotaxime sodium) 2 g powder for solution for injection vial
Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Product containing precisely cefpodoxime (as cefpodoxime proxetil) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)
Product containing precisely cefpodoxime 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Product containing precisely cefpodoxime (as cefpodoxime proxetil) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Product containing precisely cefpodoxime proxetil 200 milligram/1 each conventional release oral tablet Cefpodoxime (as cefpodoxime proxetil) 200 mg oral tablet
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 1 gram/1 vial powder for conventional release solution for injection Ceftazidime 1 g powder for solution for injection vial
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 2 gram/1 vial powder for conventional release solution for injection Ceftazidime 2 g powder for solution for injection vial
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 250 milligram/1 vial powder for conventional release solution for injection Ceftazidime 250 mg powder for solution for injection vial
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 3 gram/1 vial powder for conventional release solution for injection Ceftazidime 3 g powder for solution for injection vial
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 500 milligram/1 vial powder for conventional release solution for injection Ceftazidime 500 mg powder for solution for injection vial
Product containing precisely cefuroxime (as cefuroxime sodium) 1.5 gram/50 milliliter conventional release solution for infusion bag Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection
Product containing precisely cefuroxime (as cefuroxime sodium) 750 milligram/50 milliliter conventional release solution for infusion bag Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely cefuroxime 125 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefuroxime 250 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefuroxime 500 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefuroxime axetil 125 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefuroxime axetil 250 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefuroxime axetil 500 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely cefuroxime axetil 601.44 milligram/1 each conventional release oral tablet Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oromucosal spray (clinical drug)
Product containing precisely chlorphenamine 4 milligram/1 each conventional release oral tablet Product containing precisely chlorphenamine maleate 4 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely choline salicylate 87 milligram/1 gram conventional release oral gel Product containing precisely choline salicylate 87 milligram/1 gram conventional release oromucosal gel (clinical drug)
Product containing precisely ciclosporin 1 milligram/1 milliliter conventional release eye drops (clinical drug) Product containing precisely ciclosporin 1 milligram/1 milliliter conventional release emulsion for eye drops (clinical drug)
Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for infusion ampule Product containing precisely ciclosporin 50 milligram/1 milliliter conventional release solution for injection (clinical drug)
Product containing precisely cidofovir 375 milligram/5 milliliter conventional release solution for infusion vial Cidofovir 75 mg/mL solution for injection
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug)
Product containing precisely cilazapril (as cilazapril monohydrate) 1 milligram/1 each conventional release oral tablet (clinical drug) Cilazapril 1 mg oral tablet
Product containing precisely cilazapril (as cilazapril monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Cilazapril 5 mg oral tablet
Product containing precisely cilazapril (as cilazapril monohydrate) 500 microgram/1 each conventional release oral tablet (clinical drug) Product containing precisely cilazapril 500 microgram/1 each conventional release oral tablet (clinical drug)
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Ciprofloxacin 100 mg/mL oral suspension
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 100 milligram/50 milliliter conventional release solution for infusion bottle Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 200 milligram/100 milliliter conventional release solution for infusion bag Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 400 milligram/200 milliliter conventional release solution for infusion bag Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection
Product containing precisely ciprofloxacin 100 milligram/1 each conventional release oral tablet Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug)
Product containing precisely ciprofloxacin 250 milligram/1 each conventional release oral tablet Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely ciprofloxacin 500 milligram/1 each conventional release oral tablet Ciprofloxacin (as ciprofloxacin hydrochloride) 500 mg oral tablet
Product containing precisely ciprofloxacin 750 milligram/1 each conventional release oral tablet Ciprofloxacin (as ciprofloxacin hydrochloride) 750 mg oral tablet
Product containing precisely ciprofloxacin hydrochloride 100 milligram/1 each conventional release oral tablet Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely ciprofloxacin hydrochloride 250 milligram/1 each conventional release oral tablet Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug)
Product containing precisely ciprofloxacin hydrochloride 500 milligram/1 each conventional release oral tablet Ciprofloxacin (as ciprofloxacin hydrochloride) 500 mg oral tablet
Product containing precisely ciprofloxacin hydrochloride 750 milligram/1 each conventional release oral tablet Ciprofloxacin (as ciprofloxacin hydrochloride) 750 mg oral tablet
Product containing precisely cisapride (as cisapride monohydrate) 1 milligram/1 milliliter conventional release oral suspension Cisapride 1 mg/mL oral suspension
Product containing precisely cisapride (as cisapride monohydrate) 10 milligram/1 each conventional release oral tablet (clinical drug) Cisapride 10 mg oral tablet
Product containing precisely cladribine 10 milligram/10 milliliter conventional release solution for infusion vial Cladribine 1 mg/mL solution for injection
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug)
Product containing precisely clemastine 1 milligram/1 each conventional release oral tablet Clemastine (as clemastine fumarate hydrochloride) 1 mg oral tablet
Product containing precisely clemastine 1.34 milligram/1 each conventional release oral tablet Clemastine fumarate 1.34 mg oral tablet

Start Previous Page 107 of 205 Next End


Reference Sets

Reference set descriptor

Back to Start